SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-032535
Filing Date
2023-05-26
Accepted
2023-05-26 16:18:59
Documents
2
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4044
2 POA DOCUMENT poa.txt EX-24 3246
  Complete submission text file 0001209191-23-032535.txt   8674
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Issuer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LONGBOARD PHARMACEUTICALS, INC. 4275 EXECUTIVE DRIVE, SUITE 950 LA JOLLA CA 92037
Business Address
Tiller Jane (Reporting) CIK: 0001892867 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40192 | Film No.: 23969198